PCDH20 downregulates the activation of Wnt/β-catenin signaling in hepatocellular carcinoma and hypo-pharyngeal squamous cell carcinoma, whereas the mechanism of PCDH20 inhibiting ESCC remains unknown. Here, PCDH20 is linked to esophageal squamous cell carcinoma.